Pulmonary Medicine : Welcome to Medscape Pulmonary Medicine, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles ...

Latest medical research on lung disease. Learn about the symptoms of chronic obstructive pulmonary disease (COPD), emphysema, and lung cancer along with the latest treatment information.

French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).

Never-smokers are increasingly diagnosed with lung cancer due to genetic factors, radon exposure, and pollutants. Women and certain populations are at higher risk.

BeiGene abandons TIGIT antibody after lung cancer flop BeiGene has decided to stop the development of its TIGIT-targeting drug ociperlimab in yet another setback for the drug class.

Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways.